Page last updated: 2024-08-24

venlafaxine hydrochloride and Granulocytic Leukemia, Chronic

venlafaxine hydrochloride has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bell, C; Hobbs, G; Signorelli, J	1

Other Studies

1 other study(ies) available for venlafaxine hydrochloride and Granulocytic Leukemia, Chronic

Article	Year
Anxiety exacerbation in a patient with chronic myeloid leukemia receiving dasatinib and venlafaxine. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:7 Topics: Aged; Anxiety; Dasatinib; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Kinase Inhibitors; Quality of Life; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride	2023

Article

Year

Anxiety exacerbation in a patient with chronic myeloid leukemia receiving dasatinib and venlafaxine.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:7

Topics: Aged; Anxiety; Dasatinib; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Kinase Inhibitors; Quality of Life; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride

2023